Docusign Inc. $DOCU Shares Sold by Nomura Asset Management Co. Ltd.

Nomura Asset Management Co. Ltd. lowered its stake in Docusign Inc. (NASDAQ:DOCU) by 9.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 127,357 shares of the company’s stock after selling 13,417 shares during the quarter. Nomura Asset Management Co. Ltd. owned about 0.06% of Docusign worth $8,711,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DOCU. Nordea Investment Management AB lifted its holdings in Docusign by 3.8% in the 4th quarter. Nordea Investment Management AB now owns 1,198,634 shares of the company’s stock valued at $82,502,000 after acquiring an additional 43,810 shares during the last quarter. Step Capital Management Pte. Ltd. acquired a new stake in Docusign in the 4th quarter valued at about $2,052,000. Retirement Systems of Alabama lifted its holdings in Docusign by 4.9% in the 4th quarter. Retirement Systems of Alabama now owns 544,473 shares of the company’s stock valued at $37,242,000 after acquiring an additional 25,367 shares during the last quarter. Envestnet Asset Management Inc. lifted its holdings in Docusign by 11.1% in the 3rd quarter. Envestnet Asset Management Inc. now owns 312,859 shares of the company’s stock valued at $22,554,000 after acquiring an additional 31,334 shares during the last quarter. Finally, South Dakota Investment Council lifted its holdings in Docusign by 140.6% in the 3rd quarter. South Dakota Investment Council now owns 53,373 shares of the company’s stock valued at $3,848,000 after acquiring an additional 31,192 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have weighed in on DOCU. JPMorgan Chase & Co. cut their price target on shares of Docusign from $78.00 to $65.00 and set a “neutral” rating for the company in a report on Wednesday, March 18th. HSBC set a $53.00 price target on shares of Docusign in a report on Friday, February 13th. Citigroup downgraded shares of Docusign from a “buy” rating to a “neutral” rating and cut their price target for the company from $99.00 to $50.00 in a report on Friday, April 10th. Citizens Jmp cut their price target on shares of Docusign from $124.00 to $86.00 and set a “market outperform” rating for the company in a report on Wednesday, March 18th. Finally, UBS Group cut their price target on shares of Docusign from $75.00 to $54.00 and set a “neutral” rating for the company in a report on Wednesday, March 18th. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $61.40.

Insider Buying and Selling

In other news, CRO Paula Hansen sold 6,000 shares of the company’s stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $46.84, for a total value of $281,040.00. Following the transaction, the executive owned 79,233 shares in the company, valued at $3,711,273.72. This represents a 7.04% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mary Agnes Wilderotter sold 3,000 shares of the company’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $48.15, for a total value of $144,450.00. Following the completion of the transaction, the director owned 59,803 shares in the company, valued at $2,879,514.45. This represents a 4.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 65,126 shares of company stock worth $3,107,875 over the last ninety days. 0.59% of the stock is currently owned by corporate insiders.

Docusign Price Performance

Shares of DOCU opened at $52.40 on Thursday. The company has a market capitalization of $10.18 billion, a price-to-earnings ratio of 35.41, a P/E/G ratio of 2.10 and a beta of 0.92. Docusign Inc. has a fifty-two week low of $40.16 and a fifty-two week high of $94.67. The business’s 50-day moving average is $47.64 and its 200-day moving average is $54.33.

Docusign (NASDAQ:DOCU) last issued its earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.06. The company had revenue of $836.86 million for the quarter, compared to the consensus estimate of $828.23 million. Docusign had a return on equity of 16.86% and a net margin of 9.60%.The firm’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.86 EPS. Equities research analysts expect that Docusign Inc. will post 1.76 earnings per share for the current fiscal year.

Docusign declared that its Board of Directors has authorized a share repurchase plan on Tuesday, March 17th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to reacquire up to 21% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board of directors believes its shares are undervalued.

Docusign News Roundup

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Docusign announced its app is now available in ChatGPT and Codex, extending its Intelligent Agreement Management platform into OpenAI products and potentially improving adoption by making agreement workflows easier to use. Docusign Brings Trusted Agreement Intelligence and Workflows into ChatGPT and Codex
• Positive Sentiment: The company appointed Graham Sheldon as Chief Product Officer, a move aimed at accelerating its AI-focused product strategy and strengthening product execution. Docusign Appoints Graham Sheldon as Chief Product Officer to Accelerate Intelligent Agreement Management Vision
• Neutral Sentiment: Investor focus is centered on Thursday’s earnings release, where the key question is whether recent AI initiatives are driving enough momentum to support the stock. DocuSign (DOCU) Q1 Earnings Report Preview: What To Look For
• Neutral Sentiment: Multiple directors sold small amounts of stock, including Anna Marrs, James A. Beer, and Teresa Briggs, but the trades were modest and were executed under Rule 10b5-1 plans, which typically limits their significance. SEC filing: Anna Marrs Form 4
• Neutral Sentiment: Recent commentary also highlighted Docusign as an earnings-watch name, reinforcing that the stock may move on management’s outlook and proof of execution rather than the insider activity. Dear Docusign Stock Fans, Mark Your Calendars for June 4

Docusign Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.